| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.278 | 31.181 | 32.025 | 51.497 | 48.189 | 132.435 | 234.822 | 236.493 | 292.473 |
| Total Income - EUR | - | 20.278 | 31.181 | 32.025 | 51.497 | 48.189 | 132.549 | 236.769 | 247.496 | 314.574 |
| Total Expenses - EUR | - | 9.360 | 13.170 | 22.333 | 15.016 | 21.808 | 103.559 | 147.512 | 193.982 | 293.018 |
| Gross Profit/Loss - EUR | - | 10.918 | 18.012 | 9.692 | 36.481 | 26.381 | 28.989 | 89.257 | 53.514 | 21.556 |
| Net Profit/Loss - EUR | - | 10.310 | 17.076 | 8.731 | 34.937 | 25.010 | 27.211 | 86.955 | 51.480 | 18.225 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 |
Check the financial reports for the company - Cardiometabolic Group Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 19 | 6.657 | 4.723 | 2.908 | 7.588 | 10.896 | 13.538 | 146.343 | 659.172 |
| Current Assets | - | 13.333 | 16.514 | 5.697 | 32.814 | 21.072 | 80.274 | 110.868 | 152.181 | 168.375 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.806 | 2.003 | 2.981 | 27.000 | 507 | 44.343 | 51.247 | 66.086 | 157.566 |
| Cash | - | 11.527 | 14.511 | 2.717 | 5.814 | 20.565 | 35.931 | 59.621 | 86.095 | 10.809 |
| Shareholders Funds | - | 10.354 | 17.120 | 8.775 | 34.987 | 25.060 | 51.715 | 87.004 | 138.220 | 155.672 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.998 | 6.051 | 1.646 | 735 | 3.600 | 43.859 | 37.860 | 28.654 | 566.691 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 131.804 | 107.191 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiometabolic Group Srl